Please login to your online account to display your discounted pricing

Promega™ Recombinant RNasin™ Ribonuclease Inhibitor DFS Item

Ideal for any application where eukaryotic RNase contamination is a potential problem

Manufacturer: promega™  N2515

 View more versions of this product


U.S. Patents 4,966,964, 5,019,556, and 5,266,687; Australian Patents 616881 and 641261, are exclusively licensed to Promega Corporation.
U.S. Patent 5,552,302, Australian Patent 646803.

Catalog No. PR-N2515

  • / Each

Description & Specifications


Quantity 10000U
Storage Requirements Store at -20°C.
Concentration 20 to 40U/μL
For Use With (Application) RT-PCR, protection of mRNA in cDNA synthesis reactions, in-vitro transcription/translation, Increase yield and activity of polysomes, improvement of in-vitro virus replication, improvement of RNA translation in homologous systems